CS161826B2 - - Google Patents
Info
- Publication number
- CS161826B2 CS161826B2 CS1762A CS176259A CS161826B2 CS 161826 B2 CS161826 B2 CS 161826B2 CS 1762 A CS1762 A CS 1762A CS 176259 A CS176259 A CS 176259A CS 161826 B2 CS161826 B2 CS 161826B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Conveying And Assembling Of Building Elements In Situ (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL226774 | 1958-04-12 | ||
| NL232312 | 1958-10-15 | ||
| NL236884 | 1959-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS161826B2 true CS161826B2 (US06373033-20020416-M00002.png) | 1975-06-10 |
Family
ID=27351008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS2095A CS149567B2 (US06373033-20020416-M00002.png) | 1958-04-12 | 1959-04-10 | |
| CS1762A CS161826B2 (US06373033-20020416-M00002.png) | 1958-04-12 | 1959-04-10 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS2095A CS149567B2 (US06373033-20020416-M00002.png) | 1958-04-12 | 1959-04-10 |
Country Status (13)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH455765A (de) * | 1958-04-12 | 1968-05-15 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
| BE634693A (US06373033-20020416-M00002.png) * | 1962-07-10 | |||
| US3235573A (en) * | 1962-12-20 | 1966-02-15 | Syntex Corp | 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives |
| NL123937C (US06373033-20020416-M00002.png) * | 1963-11-06 | |||
| US3463852A (en) * | 1966-01-14 | 1969-08-26 | Schering Corp | Treating allergies with steroids of the pregnane series |
| CH481904A (de) * | 1966-06-10 | 1969-11-30 | Hoffmann La Roche | Verfahren zur Herstellung von neuen 9B, 10a-Steroiden |
| GB1266361A (US06373033-20020416-M00002.png) * | 1969-07-16 | 1972-03-08 | ||
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| CN113880904B (zh) * | 2020-07-01 | 2024-04-12 | 苏州朗科生物技术股份有限公司 | 合成地屈孕酮的新方法及化合物 |
| CN114057820B (zh) * | 2021-11-15 | 2023-06-27 | 湖南科瑞生物制药股份有限公司 | 一种地屈孕酮的精制方法 |
| CN114957370B (zh) * | 2021-12-06 | 2023-09-19 | 湖南醇康医药科技有限公司 | 一种地屈孕酮的制备和纯化方法 |
| CN114957369B (zh) * | 2021-12-07 | 2023-10-31 | 湖南醇康医药科技有限公司 | 一种地屈孕酮的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE882399C (de) * | 1937-11-28 | 1953-07-09 | Schering Ag | Verfahren zur Darstellung von 17-AEthinyl-?-androstenol-17-on-3 und dessen Derivaten |
| US2752337A (en) * | 1951-06-28 | 1956-06-26 | Upjohn Co | Steroid enamines |
| US2739974A (en) * | 1953-04-06 | 1956-03-27 | Searle & Co | Process of preparing delta4,6-3-ketosteroids |
| US2871245A (en) * | 1956-06-19 | 1959-01-27 | Ciba Pharm Prod Inc | New 1-dehydro-testosterones and esters thereof |
| US2867630A (en) * | 1958-06-09 | 1959-01-06 | Upjohn Co | 6-fluoro androstenes |
| CH455765A (de) * | 1958-04-12 | 1968-05-15 | Philips Nv | Verfahren zur Herstellung neuer Steroide |
| GB956691A (en) * | 1961-10-05 | 1964-04-29 | British Drug Houses Ltd | 3-unsubstituted-í¸-androstene compounds |
-
1959
- 1959-04-09 CH CH343566A patent/CH455765A/de unknown
- 1959-04-09 DE DEN16529A patent/DE1253707B/de active Pending
- 1959-04-09 CH CH343466A patent/CH430710A/de unknown
- 1959-04-09 CH CH343866A patent/CH434244A/de unknown
- 1959-04-09 CH CH344166A patent/CH432506A/de unknown
- 1959-04-09 CH CH343666A patent/CH415613A/de unknown
- 1959-04-09 SE SE3390/59A patent/SE342814B/xx unknown
- 1959-04-09 NO NO131412A patent/NO122835B/no unknown
- 1959-04-09 CH CH344066A patent/CH432505A/de unknown
- 1959-04-09 CH CH343966A patent/CH420131A/de unknown
- 1959-04-09 CH CH436066A patent/CH428720A/de unknown
- 1959-04-09 CH CH343766A patent/CH420130A/de unknown
- 1959-04-09 CH CH527966A patent/CH416612A/de unknown
- 1959-04-09 CH CH436166A patent/CH415614A/de unknown
- 1959-04-09 CH CH7177059A patent/CH464183A/de unknown
- 1959-04-09 CH CH1881566A patent/CH441299A/de unknown
- 1959-04-09 CH CH527866A patent/CH415615A/de unknown
- 1959-04-10 CS CS2095A patent/CS149567B2/cs unknown
- 1959-04-10 US US805436A patent/US3192201A/en not_active Expired - Lifetime
- 1959-04-10 ES ES0248593A patent/ES248593A1/es not_active Expired
- 1959-04-10 CS CS1762A patent/CS161826B2/cs unknown
- 1959-04-11 DK DK126859AA patent/DK110201C/da active
- 1959-04-11 DK DK362761AA patent/DK108571C/da active
- 1959-04-11 AT AT03676/68A patent/AT287213B/de not_active IP Right Cessation
- 1959-04-11 FI FI0624/59A patent/FI42083B/fi active
- 1959-04-11 DK DK363161AA patent/DK107871C/da active
- 1959-04-11 AT AT06986/65A patent/AT281307B/de not_active IP Right Cessation
- 1959-04-11 DK DK363061AA patent/DK103510C/da active
- 1959-04-12 GB GB639/63D patent/GB929279A/en not_active Expired
- 1959-04-12 GB GB12025/59A patent/GB929271A/en not_active Expired
- 1959-04-12 GB GB637/63A patent/GB929277A/en not_active Expired
- 1959-04-12 GB GB639/63A patent/GB929276A/en not_active Expired
- 1959-04-12 GB GB638/63A patent/GB929278A/en not_active Expired
-
1960
- 1960-08-30 FR FR837281A patent/FR953M/fr active Active
-
1961
- 1961-09-12 DK DK362961AA patent/DK124079B/da unknown
- 1961-09-12 DK DK362661AA patent/DK118503B/da unknown
-
1962
- 1962-11-08 DK DK481862AA patent/DK115038B/da unknown
- 1962-11-20 FI FI2082/62A patent/FI42212B/fi active
-
1964
- 1964-02-07 US US343233A patent/US3373172A/en not_active Expired - Lifetime
- 1964-12-31 OA OA51294A patent/OA02640A/xx unknown
-
1965
- 1965-11-29 SE SE15412/65A patent/SE341401B/xx unknown
- 1965-11-29 SE SE15410/65A patent/SE341397B/xx unknown
- 1965-11-29 SE SE15413/65A patent/SE341398B/xx unknown
- 1965-11-29 SE SE15411/65A patent/SE341400B/xx unknown
- 1965-11-29 SE SE15415/65A patent/SE341399B/xx unknown
- 1965-11-29 SE SE15416/65A patent/SE341848B/xx unknown
- 1965-11-29 SE SE15414/65A patent/SE341394B/xx unknown
- 1965-11-29 SE SE15417/65A patent/SE342445B/xx unknown
-
1966
- 1966-06-28 US US561292A patent/US3362968A/en not_active Expired - Lifetime
- 1966-07-15 US US565671A patent/US3445489A/en not_active Expired - Lifetime
